WilmerHale Shortlisted for LMG Life Sciences Awards

WilmerHale Shortlisted for LMG Life Sciences Awards

Recognition

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
Clients trust us to protect their most important intellectual property matters.
Guiding clients through high-stakes and sensitive investigations.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A global team handling highly complex and sensitive matters in all aspects of litigation.
We advise clients on the smartest, most cost-effective ways to challenge or defend issued patents.

WilmerHale and five of its partners have been named to the 2022 LMG Life Sciences Awards shortlist. The annual awards recognize top law firms, lawyers and in-house counsel specializing in the life sciences industry, with winners selected based on case evidence, peer feedback, client feedback and a commanding recognition of the intricacies of the market and industry.

The categories in which the firm and its lawyers are featured are as follows:

  • Life Cycle Firm of the Year – United States
  • Corporate Firm of the Year
  • Venture Capital Firm of the Year
  • Hatch-Waxman Litigation Firm of the Year – Branded 
  • Inter-Partes Review Firm of the Year 
  • Firm of the Year – Intellectual Property
  • Government Investigations Firm of the Year
  • Venture Capital Attorney of the Year – Jason Kropp
  • Hatch-Waxman Litigator of the Year – Branded – Bill Lee
  • General Patent Litigator of the Year – DC Metro – Amy Wigmore
  • General Patent Litigator of the Year – Northeast – Lisa Pirozzolo
  • Government Investigations Attorney of the Year – John Walsh

All honorees will be celebrated during the annual awards event on September 8, 2022.

 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel